Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Endocrine (2019) Vol. 65, Iss. 1, pp. 110-120
Closed Access | Times Cited: 11

Showing 11 citing articles:

Evodiamine: A review of its pharmacology, toxicity, pharmacokinetics and preparation researches
Qiang Sun, Long Xie, Jiawen Song, et al.
Journal of Ethnopharmacology (2020) Vol. 262, pp. 113164-113164
Closed Access | Times Cited: 92
Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers
Munmun Panda, Surya Kant Tripathi, Gökhan Zengin, et al.
Cell Biology and Toxicology (2022) Vol. 39, Iss. 1, pp. 1-31
Closed Access | Times Cited: 34
Function of selected natural antidiabetic compounds with potential against cancer via modulation of the PI3K/AKT/mTOR cascade
Agustina Dwi Retno Nurcahyanti, Adeline Jap, Jullietta Lady, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112138-112138
Open Access | Times Cited: 31
Anticancer effects of natural phytochemicals in anaplastic thyroid cancer (Review)
Yitian Li, Jing Zhang, Huihui Zhou, et al.
Oncology Reports (2022) Vol. 48, Iss. 3
Open Access | Times Cited: 16
Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa
Longfei Lin, Yuling Liu, Ruying Tang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9843-9870
Open Access | Times Cited: 2
Histone acetylation modifications: A potential targets for the diagnosis and treatment of papillary thyroid cancer
Chongyang Chen, Jingfang Liu
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
The Synthesis, Structural Modification and Mode of Anticancer Action of Evodiamine: A Review
Lei Yao, Meixia Fan
Recent Patents on Anti-Cancer Drug Discovery (2021) Vol. 17, Iss. 3, pp. 284-296
Closed Access | Times Cited: 9
Molecular targets and anticancer potential of evodiamine
Yangyang Wang, Hongying Ma, Acharan S. Narula, et al.
Phytochemistry Letters (2022) Vol. 52, pp. 92-103
Closed Access | Times Cited: 6
HDACs as an emerging target in endocrine tumors: a comprehensive review
E. Klieser, Bettina Neumayer, Pietro Di Fazio, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 2, pp. 143-154
Closed Access | Times Cited: 3
Evodiamine exerts anti-cancer activity including growth inhibition, cell cycle arrest, and apoptosis induction in human follicular thyroid cancers
Hui-I Yu, Hong Chang, Chieh‐Hsiang Lu, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 10, pp. 4989-4999
Closed Access
Molecular biology meets the endocrine pathologist: an appraisal of p27 in thyroid malignancy
Stephen M. Smith
Diagnostic histopathology (2020) Vol. 26, Iss. 5, pp. 216-223
Closed Access | Times Cited: 1
Page 1

Scroll to top